"Only 3 patients were in remission without adverse effects at long-term follow-up." Continue reading →
The pharmaceutical industry’s latest antidepression drug marketing campaign is being launched with collaboration of the National Institute of Mental Health (NIMH) “Real Men, Real Depression campaign http://menanddepression.nimh.nih.gov/infopage.asp?ID=1 Continue reading →
The pharmaceutical industry’s latest antidepression drug marketing campaign is being launched with collaboration of the National Institute of Mental Health (NIMH)— Continue reading →
The Wall Street Journal and Bloomberg News report about a case involving Neuropsychopharmacology, the official journal of the American College of Neuropsychopharmacology (ACNP) that will likely go down in history as psychiatry’s Watergate.
Continue reading →
Operating like thieves under the cover of darkness, prominent academic-based "authorities" in medical specialties have debased academic standards and sold their reputations for cash- Continue reading →
An OpEd in The New York Times (below) is trumpeting psychiatry’s latest “cure” for depression: it requires surgical implantation of electrodes in the brain, continued “maintenance” with powerful psychotropic drugs, and it costs $40,000. Continue reading →
A Come Back for Psychosurgery? Wed, 6 Aug 2003 The Los Angeles Times reports that experimental psychosurgery is once again on the rise – at Harvard’s Massachusetts General Hospital and Brown University. It is acknowledged that “Researchers still do not fully understand . . . Continue reading →